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1. Materials and Reagents 
1-Adamantanecarboxylic acid, 2-(2-aminoethoxy)ethanol, 9,10-anthracenediyl-
bis(methylene)dimalonic acid (ABDA), boron trifluoride diethyl etherate (BF3⋅Et2O), copper 
sulfate pentahydrate (CuSO4·5H2O), 4’,6-diamidino-2-phenylindole (DAPI), 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ), 2’,7’-dichlorodihydrofluorescein diacetate (DCFH-DA), 
dichloromethane (DCM, 99.5%), 4-(dimethylamino)pyridine (DMAP), dimethylformamide 
(DMF, 99.5%), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 1,3-
diphenylisobenzofuran (DPBF), Dulbecco’s modified Eagle’s medium (DMEM), ethyl acetate 
(EtOAc, 99.5%), fetal bovine serum (FBS), 4-hydroxybenzaldehyde, 1-iodo-2,5-pyrrolidinedione 
(NIS), LysoTracker probes (Green DND), α-D-mannose, methanol (MeOH, 99.5%), phosphate 
buffered saline (PBS, pH 7.4) buffer, piperdine, sodium ascorbate, tetrahydrofuran (THF, 99.0%), 
thionyl chloride (SOCl2), p-toluenesulfonic acid (pTsOH), p-toluenesulfonyl chloride (TsCl), 
triethylamine (Et3N), trifluoroacetic acid (TFA), trimethylsilyl trifluoromethanesulfonate 
(TMSOTf) were purchased commercially without further purification. All aqueous solutions were 
prepared using ultrapure water from Milli-Q system (Millipore, USA). 
 
2. Instruments 
Transmission electron microscopy (TEM) images were captured by JEOL JEM-2100 TEM 
at 200 kV. 1H NMR spectra were recorded on a Bruker AVANCE 400 MHz NMR spectrometer. 
UV-vis absorption spectra and Fluorescence spectra were recorded on a Hitachi U-3900 UV-vis 
spectrophotometer and a Hitachi F-7000 spectrophotometer, respectively. The Integrating  Sphere  
(IS)  consists  of  a  120 mm  inside  diameter  spherical  cavity, which is machined from 
BENFLEC block (Edinburgh FLS920).  This is then surrounded by an aluminium shell for 
handling and protection. The internal reflection material was suppressed polytetrafluoroethylene 
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(PTFE, 90% reflectivity), and the wavelength range was from 250 nm to 2500 nm. To determine 
the absolute quantum yield (Φ) of the compound, the excitation wavelength was set at 640 nm. 
The scattering spectral range of blank and sample was from 630 nm to 650 nm, and the emission 
spectral range was from 650 nm to 800 nm. Hydrodynamic diameter and zeta potential 
measurements were performed at 25 °C using a Malvern Zetasizer NanoZS instrument. All of the 
measurements were performed with the nanoparticles suspended in filtered water or filtered cell 
culture media at a concentration of 30 μg/mL. A Nikon confocal microscope was used for cell 
imaging. An LED lamp was used with a light density of 20 mW/cm2, which was monitored by 






































































































Scheme S1. Synthetic route of BTA. 
 
 S-5 
3.1 Synthesis of compound 1 
To a solution of 1-adamantanecarboxylic acid (5.5 g, 30.51 mmol) in SOCl2 (8 mL) was added a 
catalytic amount of DMAP. The reaction mixture was heated to reflux for 12 h. After the mixture 
was cooled to room temperature, the solvent was removed under reduced pressure. The residue 
was dissolved in anhydrous THF (30 mL), and then added dropwise to a solution of 2-(2-
aminoethoxy)ethanol (8.0 g, 76.09 mmol) in THF (20 mL) with cooling in an ice bath. After 
stirring for 4 h at room temperature, the reaction mixture was diluted with DCM (250 mL), and 
washed with saturated brine (200 mL). The organic layer was dried over anhydrous Na2SO4 and 
the solvent was evaporated in vacuo. The crude product was purified by column chromatography 
on silica gel (DCM/MeOH = 20:1) to afford 1 as a colorless oil (7.4 g, yield: 90%). 1H NMR 
(400 MHz, CDCl3) δ: 6.03 (br, 1H), 3.75 (dd, J = 5.2 Hz, 2H), 3.61 – 3.54 (m, 4H), 3.46 (dd, J = 
10.2, 5.1 Hz, 2H), 2.04 (s, 3H), 2.00 (s, 1H), 1.85 (d, J = 2.7 Hz, 6H), 1.71 (q, J = 8.0 Hz, 6H). 
13C NMR (101 MHz, CDCl3) δ: 178.43, 72.30, 70.04, 61.69, 40.67, 39.22, 39.11, 36.55, 28.16. 
ESI-MS: m/z calcd for C15H25NO3: 267.4; found: 267.2 [M]+. 
 
3.2 Synthesis of compound 2 
Compound 1 (7.9 g, 29.66 mmol) and Et3N (6.6 mL, 47.46 mmol) were dissolved in DCM (150 
mL), and a solution of p-toluenesulfonyl chloride (9.0 g, 47.46 mmol) in DCM (70 mL) was 
added dropwise to the mixture over 2 h. After stirring for 12 h at room temperature, the mixture 
was diluted with DCM (400 mL), and washed three times with water (400 mL). The organic layer 
was dried over anhydrous Na2SO4 and the solvent was evaporated in vacuo. The crude product 
was purified by column chromatography on silica gel (DCM/MeOH = 25:1) to afford 2 (8.1 g, 
yield: 65%). 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 
6.03 (br, 1H), 4.18 (t, J = 5.3 Hz, 2H), 3.65 (t, J = 5.2 Hz, 2H), 3.48 (t, J = 5.0 Hz, 2H), 3.40 (dd, 
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J = 5.2 Hz, 2H), 2.45 (s, 3H), 2.03 (s, 3H), 1.84 (d, J = 2.6 Hz, 6H), 1.71 (s, 6H). 13C NMR (101 
MHz, CDCl3) δ: 177.76, 144.54, 132.45, 129.48, 127.32, 69.18, 68.88, 67.78, 40.05, 38.59, 
38.39, 36.01, 27.67, 21.12. ESI-MS: m/z calcd for C22H31NO5S: 421.6; found: 421.2 [M]+. 
 
3.3 Synthesis of compound 3 
Compound 2 (1.0 g, 2.37 mmol) was dissolved under a nitrogen atmosphere in DMF (40 mL). To 
a solution of compound 2 were added 4-hydroxybenzaldehyde (320 mg, 2.61 mmol) and K2CO3 
(1.64 g, 11.86 mmol) at room temperature, and then stirred for 14 h at 90 °C. After cooling to 
room temperature, the mixture was diluted with DCM (250 mL), and washed with saturated brine 
(200 mL). The organic layer was dried over anhydrous Na2SO4 and the solvent was evaporated in 
vacuo. The crude product was purified by column chromatography on silica gel (DCM/MeOH = 
33:1) to afford 3 (0.86 g, yield: 98%). 1H NMR (400 MHz, CDCl3) δ: 9.89 (s, 1H), 7.84 (d, J = 
8.8 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H), 6.01 (br, 1H), 4.21 (t, J = 5.3 Hz, 2H), 3.86 (t, J = 5.2 Hz, 
2H), 3.62 (t, J = 5.1 Hz, 2H), 3.47 (dd, J = 5.3 Hz, 2H), 2.00 (s, 3H), 1.81 (d, J = 2.6 Hz, 6H), 
1.73 – 1.61 (m, 6H). 13C NMR (101 MHz, CDCl3) δ: 190.83, 178.25, 163.84, 132.06, 130.22, 
114.88, 70.17, 69.23, 67.67, 40.67, 39.23, 38.99, 36.53, 28.15. ESI-MS: m/z calcd for 
C22H29NO4: 371.5; found: 371.2 [M]+. 
 
3.4 Synthesis of compound 4 
To a solution of compound 3 (110 mg, 0.303 mmol) in anhydrous DCM (30 mL) were added 2,4-
dimethylpyrrole (60 mg, 0.605 mmol) and TFA (0.1 mL) at room temperature. The mixture was 
stirred under a nitrogen atmosphere for 14 h. To this solution was added 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) (0.13 g, 0.605 mmol), and stirred for 30 min at room 
temperature. After the mixture was cooled in an ice bath, Et3N (3 mL, 40.62 mmol) was added 
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dropwise to the mixture. After 30 min, BF3⋅Et2O (3 mL, 23.78 mmol) was added dropwise, and 
the reaction mixture was stirred for 10 h at 0 °C and allowed to warm to room temperature. After 
the mixture was diluted with DCM (120 mL) and washed with water (100 mL), the organic layer 
was dried over anhydrous Na2SO4. Following evaporation of the solvent, the product was 
purified by column chromatography on silica gel (DCM/EtOAc = 5:1) to give 4 (45 mg, yield: 
26%). 1H NMR (400 MHz, CDCl3) δ: 7.17 (d, J = 8.6 Hz, 2H), 7.01 (d, J = 8.7 Hz, 2H), 6.09 (br, 
1H), 5.97 (s, 2H), 4.17 (t, J = 5.2 Hz, 2H), 3.88 (t, J = 5.3, Hz 2H), 3.64 (t, J = 5.1 Hz, 2H), 3.49 
(dd, J = 10.5, 5.3 Hz, 2H), 2.54 (s, 6H), 2.03 (s, 3H), 1.86 (d, J = 2.6 Hz, 6H), 1.70 (q, J = 12.3 
Hz, 6H), 1.41 (s, 6H). 13C NMR (101 MHz, CDCl3) δ: 178.10, 159.25, 155.21, 143.07, 141.67, 
131.75, 129.19, 127.26, 121.12, 115.09, 70.04, 69.27, 67.28, 60.35, 40.59, 39.17, 38.84, 36.48, 
28.10, 14.54. ESI-MS: m/z calcd for C34H42BF2N3O3: 589.5; found: 588.4 [M-H]-. 
 
3.5 Synthesis of compound 5 
To a solution of compound 4 (0.25 g, 0.424 mmol) in DCM (20 mL) was added 1-iodo-2,5-
pyrrolidinedione (NIS) (0.24 g, 1.06 mmol) at room temperature, and stirred in the dark for 5 h. 
After the solvent was removed under reduced pressure, the residue was purified by column 
chromatography on silica gel (DCM/EtOAc = 5:1) to afford 5 (0.32 g, yield: 90%). 1H NMR (400 
MHz, CDCl3) δ: 7.14 (d, J = 8.7 Hz, 2H), 7.04 (d, J = 8.7 Hz, 2H), 6.07 (br, 1H), 4.19 (t, J = 5.3 
Hz, 2H), 3.88 (t, J = 5.1 Hz, 2H), 3.66 (t, J = 5.2 Hz, 2H), 3.50 (dd, J = 10.6, 5.3 Hz, 2H), 2.64 
(s, 6H), 2.04 (s, 3H), 1.87 (d, J = 2.6 Hz, 6H), 1.66 (q, J = 12.3 Hz, 6H), 1.43 (s, 6H). 13C NMR 
(101 MHz, CDCl3) δ: 178.15, 159.75, 156.68, 145.35, 141.44, 131.75, 129.22, 127.09, 115.50, 
85.66, 70.26, 69.36, 67.50, 40.71, 39.31, 38.95, 36.60, 28.21, 17.27, 16.10. ESI-MS: m/z calcd 
for C34H40BF2I2N3O3: 841.3; found: 841.1 [M]+. 
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3.6 Synthesis of BTA 
To a solution of compound 5 (100 mg, 0.118 mmol) in toluene (25 mL) were added compound 3 
(132 mg, 0.356 mmol), piperdine (1 mL), and a catalytic amount of pTsOH under a nitrogen 
atmosphere, and then stirred for 5 h at 140 °C. After cooling to room temperature, the reaction 
mixture was diluted with DCM (200 mL) and washed twice with water (200 mL). The organic 
layer was dried over anhydrous Na2SO4 and the solvent was evaporated in cacuo. The crude 
product was purified by column chromatography on silica gel (DCM/acetone = 2.5:1) to give 
BTA (96 mg, yield: 52%). 1H NMR (400 MHz, CDCl3) δ: 8.12 (d, J = 16.6 Hz, 2H), 7.63 – 7.56 
(m, 6H), 7.18 (d, J = 8.6 Hz, 2H), 7.06 (d,J = 8.6 Hz, 2H), 6.96 (d, J = 8.7 Hz, 4H), 6.07 (br, 3H), 
4.21 – 4.17(m, 6H), 3.89 – 3.14 (m, 6H), 3.68 – 3.61 (m, 6H), 3.52 – 3.46 (m, 6H), 2.02 (d, J = 
17.0 Hz, 9H), 1.88 (d, J = 2.5 Hz, 6H), 1.81 (d, J = 2.4 Hz, 12H), 1.78 – 1.62 (m, 18H), 1.50 (s, 
6H). 13C NMR (101 MHz, CDCl3) δ: 178.21, 160.00, 159.79, 150.52, 145.82, 139.06, 138.63, 
133.35, 129.97, 129.79, 129.35, 127.71, 117.00, 115.51, 115.02, 82.83, 70.31, 70.23, 69.53, 
69.41, 67.54, 40.77, 40.71, 39.36, 39.28, 39.03, 39.00, 36.64, 36.61, 28.25, 28.23, 17.84. ESI-




































































Scheme S2. Synthetic route of CD-Man7. 
 
4.1 Synthesis of compound 7 
To a solution of α-D-mannose (3.0 g, 17 mmol) in anhydrous pyridine (30 mL) were added a 
catalytic amount of DMAP and acetic anhydride (12 mL, 130 mmol) successively at 0 °C,  and 
stirred overnight at room temperature. The solvent was removed under reduced pressure to give 
the crude product 6. Compound 6 (6.2 g, 16 mmol) was dissolved under a nitrogen atmosphere in 
anhydrous DCM (75 mL), and to this solution was added propargyl alcohol (1 mL, 18 mmol) and 
TMSOTf (3.5 mL, 19.2 mmol) successively at 0 °C. After stirring for 5 min at 0 °C, the reaction 
mixture was allowed to warm to room temperature, and stirred until TLC indicated that the 
starting material disappeared. After the reaction was quenched with saturated aqueous K2CO3 and 
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diluted with DCM, the organic layer was dried over MgSO4. After the solution was filtered, the 
solvent was removed under reduced pressure and the product was purified by column 
chromatography on silica gel (petroleum ether/EtOAc = 10:1 to 3:1) to afford 7 (4.0 g, yield: 
64%). 1H NMR (400 MHz; CDCl3) δ: 5.37–5.30 (m, 2H), 5.28 (t, J=2.5Hz, 1H), 5.25 (m, 1H), 
5.04 (d, J=1.5Hz, 1H), 4.32–4.26 (m, 3H), 4.12 (dd, J=2.4Hz, 12.3Hz, 1H), 4.03 (m, 1H), 4.01 ( 
m, 1H), 2.47 (t, J=2.4Hz, 1H), 2.18–1.99 (s, 12H). ESI-MS: m/z calcd for C17H22O10: 386.12; 
found: 409.11 [M+Na]+. 
 
4.2 Synthesis of compound 8 
Compound 7 (1.4 g, 3.6 mmol) was dissolved in the NaOMe solution (0.3 M, 30 mL). After 
stirring overnight at room temperature, the reaction mixture was quenched by neutralization with 
Amberlite IR-120 resin (H+ form). After filtration to remove the resin, the solvent was evaporated 
in cacuo to afford 8 (0.7 g, yield: 89%). 1H NMR (400 MHz, CD3OD) δ: 4.95 (s, 1H), 4.25 (d, 
J=1.9Hz, 2H), 3.81 (d, J=10.42Hz, 1H), 3.76 (m, 1H), 3.72–3.54 (m, 3H), 3.48 (m, 1H), 2.83 (s, 
1H). ESI-MS: m/z calcd for C9H14O6: 218.08; found: 241.26 [M+Na]+. 
 
4.3 Synthesis of compound 10 
Compound 10 was synthesized as described previously.1 
 
4.4 Synthesis of CD-Man7 
To a solution of compound 8 (0.7 g, 3.2 mmol) in DMF and H2O (5 mL, 1:1) were added 
compound 10 (0.5 g, 0.4 mmol), CuSO4·5H2O (100 mg, 0.4 mmol), and sodium ascorbate (160 
mg, 0.82 mmol) at room temperature. The reaction mixture was stirred at 70 °C for 48 h. After 
the insoluble solid was removed by filtration, the solvent was removed under reduced pressure. 
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The residue was dissolved in H2O and purified on a Sephadex G25 column with H2O as the 
eluent. The product was lyophilized to give CD-Man7 (0.7 g, yield: 71%). 1H NMR (400 MHz, 
D2O) δ: 8.08–8.01 (m, 7H), 5.13 (d, J = 3.1 Hz, 7H), 4.63 (d, J = 12.3 Hz, 7H), 4.48–4.34 (m, 
14H), 4.34–4.16 (m, 14H), 4.03 (t, J = 9.4 Hz, 7H), 3.90–3.51 (m, 56H), 3.4 (t, J = 9.1 Hz, 7H). 
MALDI-TOF MS: m/z calcd for C105H161N21O84: 2836.0; found: 2859.1 [M+Na]+. 
 
5. Preparation of BTA@CD-Man7 and BTA@CD 
BTA (5 mg) and CD-Man7 (14 mg) was dissolved in DMSO (5 mL) and used as a stock solution. 
Then, 30 μL of the stock solution was added dropwise into water (1 mL) under ultrasonic 
conditions. A nanoparticle dispersion of BTA@CD-Man7 in aqueous solution (30 μg/mL) was 
obtained after dialysis (MW 3500) with water to remove DMSO. BTA@CD was prepared by 
simply mixing BTA (5 mg) with β-CD (5.5 mg) using the same steps as described for the 
formation of BTA@CD-Man7 nanoparticles. To determine the amount of BTA in BTA@CD-
Man7 and BTA@CD nanoparticles, the UV-vis absorbance of BTA at 665 nm was determined in 
DMSO to obtain a standard curve of absorbance vs. concentration. After water was removed by 
lyophilization, the solid powder of nanoparticles was dissolved in DMSO. The BTA content in 
BTA@CD-Man7 and BTA@CD was estimated to be 20% and 18%, respectively. 
 
6. Detection of singlet oxygen generation in DMSO 
DPBF was used to evaluate the 1O2 generation of BTA in DMSO. In this method, DPBF was 
dissolved in DMSO (3 mL, 53 μM), and then a solution of BTA in DMSO (20 μL, 0.5 mg/mL) 
was added. The solution was then subject to light irradiation from a 665 nm LED lamp that was 
set closely (about 2 cm) to the quartz cuvette with a light density of 20 mW/cm2. At each 
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predetermined time interval, the absorption spectra of the solution were recorded after irradiation. 
DPBF in DMSO (3 mL, 53 μM) was introduced as control experiments. 
 
7. Cellular culture 
MDA-MB-231 (breast cancer) cells were cultured in DMEM, supplemented with 10% FBS and 
1% penicillin/streptomycin. MCF-10A (breast epithelial) cells were cultured in DMEM/F12 
supplemented with 5% horse serum, 1% penicillin/streptomycin, hydrocortisone (0.5 μg/mL), 
cholera toxin (100 ng/mL), insulin (10 μg/mL), and recombinant human EGF (20 ng/mL). Cells 
were maintained in a humidified, 5% CO2 atmosphere at 37 °C. 
 
8. Cellular uptake and localization 
For cellular internalization observation, MDA-MB-231 or MCF-10A cells were seeded in plastic-
bottomed Ibidi μ-dishes (35 mm) and allowed to grow for 24 h. After incubation with the 
nanoparticles for 12 or 24 h, the cells were washed three times with phosphate buffered saline 
(PBS, pH 7.4) and then fixed with 4.0% formaldehyde at room temperature for 15 min. After 
washing with PBS, the cells were stained with DAPI (1 μg/mL) for 15 min. After washing with 
PBS, the cells were subjected to confocal microscopy observation (100 × oil objective, 408/561 
nm excitation). 
    For subcellular distribution observation, MDA-MB-231 cells were seeded according to 
description abovementioned. The cells were washed three times with PBS, and then incubated 
with BTA@CD-Man7 in DMEM medium at 37 °C for 12 or 24 h. The medium was replaced with 
preheated (37 °C) medium containing LysoTracker (50 nM). After incubation for 30 min, the 
cells were washed with fresh medium and monitored live under a confocal microscope (100 × oil 
objective, 488/561 nm excitation). 
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9. Detection of 1O2 generation in live cells 
The cells were incubated with BTA@CD or BTA@CD-Man7 at a BTA-equivalent dose (9 
μg/mL) for 24 h. After the media were removed, the cells were washed three times with PBS. 
Then, the cells incubated in the medium solution containing DCFH-DA (10 μM) were irradiated 
with a 665 nm LED light (20 mM/cm2) for 5 min. After another 15 min of incubation at 37 °C, 
the cells were washed three times with PBS, and the fluorescent images of DCFH-DA staining on 
the cells were captured by excitation at 488 nm using a confocal microscope. 
 
10. PDT effects of BTA@CD-Man7 and BTA@CD on MDA-MB-231 cells 
MDA-MB-231 cells were seeded in Ibidi μ-dishes and grown in complete DMEM for 24 h. The 
medium was replaced with a fresh medium containing BTA@CD or BTA@CD-Man7 at a BTA-
equivalent dose of 9 μg/mL, and incubated for 24 h in the dark. After washing three times with 
PBS, the cells were incubated in fresh culture medium. After the irradiation with a LED light 
(665 nm, 20 mW/cm2) for 30 min, the morphology of cells was monitored under a Nikon 
fluorescent microscope (40 × objective). 
    For Calcein-AM/PI staining, MDA-MB-231 cells seeded in μ-dishes were incubated with 
BTA@CD or BTA@CD-Man7 at a BTA-equivalent dose of 9 μg/mL. After 24 h of incubation in 
the dark, MDA-MB-231 cells were washed three times with PBS. The cells were incubated in 
fresh culture medium and irradiated with or without a LED light (665 nm, 20 mW/cm2) for 30 
min. After washing three times with PBS, the cells were treated with live/dead assay reagent, 
based on the manufacture’s protocol. After washing with PBS, the cells were subjected to the 




11. Photocytotoxicity assay 
The cells were seeded into 96-well plate at a density of 1 × 104 cells per well and maintained in 
growth medium (100 μL) for 24 h. The culture medium was then replaced with fresh culture 
medium (100 μL) containing either BTA@CD or BTA@CD-Man7 at various concentrations. 
After 24 h of incubation with BTA@CD or BTA@CD-Man7, the cells were then washed three 
times with PBS and refilled with 100 μL of fresh culture medium. The plate was irradiated with a 
665 nm LED light for 30 min. The distance between the 96-well plate and light source is about 2 
cm, and the light power at the 96-well plate position is 20 mW/cm2. The cells were further 
cultured for 12 h, and the culture medium from each well was replaced with 100 μL of medium 
containing MTT solution (0.5 mg mL-1). After another 4 h of incubation, culture supernatants 
were removed, and DMSO (100 μL) was added into each well. The plate was gently shaken for 
10 min, and the absorbance intensity at 570 nm was recorded using a microplate reader (Synergy 
H4, BioTek). The relative cell viability compared to control wells that were only treated with 
medium was calculated by [A]test/[A]control, where [A]test and [A]control are the average absorbance 
of the test and control samples, respectively. 
 
12. Animal models and in vivo photodynamic therapy 
All animal procedures were compliant with the guidelines of the Chinese Animal use and Care 
Committee, and carried out ethically and humanely. Nude Bal/bc mice (~20 g, female) were 
injected subcutaneously on the right flank with MDA-MB-231 cancer cells (5 × 106 cells) 
suspended in PBS. Tumor volume was calculated using the equation of length × (width)2 × 1/2, 
where the length and width are the longest and shortest diameters (mm) of the tumor, respectively. 
When the solid tumors reached ~90 mm3, the mice were treated with either BTA@CD or 
BTA@CD-Man7 in saline (BTA, 2 mg/kg) by intravenous injection. As a control, two groups of 
 S-15 
mice were treated with the same volume of saline. The mice were randomly divided into five 
groups (four mice per group): (1) saline; ((2) saline with irradiation; (3) BTA@CD-Man7 without 
irradiation; (4) BTA@CD with irradiation; and (5) BTA@CD-Man7 with irradiation. For the 
irradiated groups, a 665 nm LED light (20 mW/cm2, 30 min) was used 24 h after injection. The 
photodynamic effects were investigated by monitoring changes in the tumor volume and body 
weight of mice. After 21 days, major organs and tumor tissues of mice from all groups were 
collected, fixed in 10% formalin solution, processed routinely into paraffin, sectioned at 5 μm, 
and stained with hematoxylin and eosin (H&E) procedure. Examined tissues included: tumor, 
heart, liver, kidney, lung, and spleen. 
 
13. Statistical Analysis 
Data were presented as means ± standard deviation (SD) from at least three independent 
experiments. Statistical significances were determined based on the Student’s t test where 





Figure S1. 1H NMR spectrum of BTA. 
 
 
Figure S2. 13C NMR spectrum of BTA. 
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Figure S3. ESI mass spectrum of BTA. 
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Figure S5. MALDI-TOF mass spectrum of CD-Man7. 
 
 
Figure S6. TEM image of larger particles formed after the DMSO solution of BTA (30 μL, 1.0 
mg/mL) was added into water (1 mL). 
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Figure S8. UV-vis absorption changes of (a) BTA and (b) BTE before and after the addition of 
CD-Man7, indicating the immobilization of CD-Man7 onto the surface of BTA nanoparticles in 
aqueous solution. 
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UV-vis absorption measurements were carried out to confirm the important roles of CD-Man7 
or β-CD on modulating and stabilizing BTA nanoparticles via β-CD/Ad complexation. And 
another three-arm BODIPY PS (denoted as BTE) with similar molecular structure but no Ad 
units was synthesized as a control model compound. After the DMSO solution of BTA (50 μL, 
1.0 mg/mL) was added into H2O (3 mL), the absorbance was depressed along with new 
emergence of a shoulder peak (Figure S8a), in comparison with the same DMSO solution (Figure 
S7a). This should be attributed to the aggregation of BTA in water. Moreover, it was found that 
the dispersion solution of BTA@CD-Man7 (or BTA@β-CD) exhibited a higher maximum 
absorbance than that of BTA alone. However, no obvious change in absorption spectra was 
detected in the case of BTE without Ad units when performing the same experiments. Such 
different behaviors in absorption experiments indicated that there should be the inclusion 
complexation of β-CD/Ad in BTA@CD-Man7 or BTA@β-CD nanoparticles, thus stabilizing 
them in aqueous solution. When using both α-CD and β-CD to prepare BTA nanoparticles, 
respectively, it was observed that β-CD served as a better stabilizer than α-CD, mainly attributed 









Figure S9. CLSM images of live MDA-MB-231 cells treated with BTA@CD-Man7 for (a) 12 h 
and (b) 24 h. Red fluorescence from BTA was clearly observed, and the green fluorescence 
marked LysoTracker-labeled lysosomes. The green and red spots are colocalized to give a yellow 
color, which should be due to BTA molecules trapped inside the cell lysosomes. Scale bar: 20 μm. 
 








































(a)                                                                 (b)
 
Figure S10. UV-vis spectra of (a) DPBF and (b) DPBF plus BTA in DMSO irradiated with a 665 
nm LED light (20 mW/cm2) at varied time. 
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Figure S11. Detection of intracellular 1O2 by DCFH-DA staining in (a) MDA-MB-231 cancer 
cells and (b) healthy MCF-10A cells incubated with BTA@CD-Man7, BTA@CD, and PBS 
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 ABDA in DMSO
 ABDA + BTA@CD-Man
7
 in water
 ABDA + BTA@CD-Man7 in DMSO
 
Figure S12. Fluorescence spectra (between 390 and 500 nm) of (a) ABDA  in DMSO, (b) ABDA 
plus BTA@CD-Man7 in water, and (c) ABDA plus BTA@CD-Man7 in DMSO after the 
irradiation (665 nm, 20 mW/cm2) for 10, 20, 30, and 40 min. (d) Plots of the fluorescence 
















Figure S13. PDT effects on MDA-MB-231 cells incubated in complete medium containing 
BTA@CD or BTA@CD-Man7 at equivalent BTA concentrations (9 μg/mL) for 24 h. Untreated 
cells were used as a control experiment. (a) Fluorescence microscope images of MDA-MB-231 
cells. Scale bar: 20 μm. (b) CLSM images of cell nuclei stained by DAPI. Blue fluorescence 
denotes the nuclei, and red fluorescence is from BTA in the cells. Scale bar: 20 μm. (c) CLSM 
 S-25 
images of live/dead assay (Calcein-AM/PI) on co-stained MDA-MB-231 cells after incubation 
with BTA@CD or BTA@CD-Man7. Scale bar: 100 μm. 
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Figure S14. Confocal images of MDA-MB-231 cancer cells treated with BTA@CD-Man7 for 24 
h followed by irradiation with a LED light (665 nm, 20 mW/cm2) for 30 min. The cells were co-
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Figure S16. H&E staining of the heart, liver, kidney, lung, and spleen from mice after various 
treatments with (1) saline, (2) saline with irradiation, (3) BTA@CD-Man7 without irradiation, (4) 
BTA@CD with irradiation, and (5) BTA@CD-Man7 with irradiation. These mice were from the 
same experiments shown in Figure 4 and S15. The results did not show any histological 








Table S1. Absorbance and fluorescence data of BTA, BTA@CD, and BTA@CD-Man7. 
 Solvents λmax,abs (nm) λem (nm) Φ 
BTA DMSO 665 697 28% 
BTA@CD H2O N.A. N.A. N.A. 
BTA@CD DMSO 665 697 29% 
BTA@CD-Man7 H2O N.A. N.A. N.A. 
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